SEARCH

SEARCH BY CITATION

References

  • 1
    Wardlaw AJ, Brightling CE, Green R, Woltmann G, Bradding P, Pavord ID. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 2002;103:201211.
  • 2
    Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-Cell Infiltration of Airway Smooth Muscle in Asthma. N Engl J Med 2002;346:16991705.
  • 3
    Berger P, Girodet PO, Begueret H, Ousova O, Perng DW, Marthan R et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J 2003;17:21392141.
  • 4
    Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, Hughes JM et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005;171:11031108.
  • 5
    El-Shazly A, Berger P, Girodet PO, Ousova O, Fayon M, Vernejoux JM et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 2006;176:18601868.
  • 6
    Pepe C, Foley S, Shannon J, Lemiere C, Olivenstein R, Ernst P et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005;116:544549.
  • 7
    Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004;169:10011006.
  • 8
    Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:13601368.
  • 9
    Johnson P, Roth M, Tamm M, Hughes M, Ge Q, King G et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474477.
  • 10
    Trian T, Benard G, Begueret H, Rossignol R, Girodet PO, Ghosh D et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007;204:31733181.
  • 11
    Begueret H, Berger P, Vernejoux JM, Dubuisson L, Marthan R, Tunon-de-Lara JM. Inflammation of bronchial smooth muscle in allergic asthma. Thorax. 2007;62:815.
  • 12
    Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:75567562.
  • 13
    Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171:380389.
  • 14
    Kaur D, Saunders R, Berger P, Siddiqui S, Woodman L, Wardlaw A et al. Airway smooth muscle and mast cell-derived CCL19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med 2006;174:11791188.
  • 15
    Hirst SJ, Hallsworth MP, Peng Q, Lee TH. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med 2002;165:11611171.
  • 16
    Sutcliffe A, Kaur D, Page S, Woodman L, Armour CL, Baraket M et al. Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax. 2006;61:657662.
  • 17
    Brightling CE, Kaur D, Berger P, Morgan AJ, Wardlaw AJ, Bradding P. Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol 2005;77:759766.
  • 18
    Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981;256:1193911943.
  • 19
    Bradding P, Okayama Y, Kambe N, Saito H. Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J Leukoc Biol 2003;73:614620.
  • 20
    Vermes I, Haanen C, Steffensnakken H, Reutelingsperger C. A novel assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin-V. J Immunol Methods 1995;184:3951.
  • 21
    Morgan AJ, Symon FA, Berry MA, Pavord ID, Corrigan CJ, Wardlaw AJ. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR3 and CCR4. J Allergy Clin Immunol 2005;116:594600.
  • 22
    Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997;100:11371143.
  • 23
    Romagnani P, De Paulis A, Beltrame C, Annunziato F, Dente V, Maggi E et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999;155:11951204.
  • 24
    Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:63216329.
  • 25
    De Lucca G. Recent developments in CCR3 antagonists. Curr Opin Drug Discov Devel 2006;9:516524.
  • 26
    Stellato C, Brummet ME, Plitt JR, Shahabuddin S, Baroody FM, Liu MC et al. Cutting Edge: Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J Immunol 2001;166:14571461.
  • 27
    Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000;102:21852189.
  • 28
    Joubert P, Lajoie-Kadoch S, Labonte I, Gounni AS, Maghni K, Wellemans V et al. CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 2005;175:27022708.
  • 29
    Roque M, Kim WJH, Gazdoin M, Malik A, Reis ED, Fallon JT et al. CCR2 Deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 2002;22:554559.
  • 30
    Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I{kappa}B kinase, and nuclear factor-{kappa}B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004;279:31883196.
  • 31
    Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu L et al. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J 2003;373:547558.
  • 32
    Kodali RB, Kim WJH, Galaria II, Miller C, Schecter AD, Lira SA et al. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2004;24:12111216.
  • 33
    Chan V, Burgess JK, Ratoff JC, O’Connor BJ, Greenough A, Lee TH et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006;174:379385.
  • 34
    Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 2006;176:37883795.